MedTrace Logo

Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Uganda

NCT01184911 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2015-03-05

No results posted yet for this study

Summary

The effectiveness of sulfadoxine-pyrimethamine (SP) as intermittent preventive treatment in pregnancy in malaria-endemic areas the effectiveness and efficacy of SP may be compromised by increased SP resistance. This study will evaluate the efficacy of SP by giving SP to asymptomatic parasitemic pregnant women and following them to determine the rates of parasite clearance.

Conditions

  • Intermittent Preventive Treatment
  • Placental Malaria

Interventions

DRUG

Sulfadoxine-pyrimethamine

Sulfadoxine-pyrimethamine tablets, once

Sponsors & Collaborators

Principal Investigators

  • Veronica Ades, MD, MPH · University of California, San Francisco

  • Scott Filler, MD, DTM&H · Centers for Disease Control and Prevention

  • Moses Kamya, MBChB, MMed, MPH, PhD · Uganda Malaria Surveillance Project

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01184911 on ClinicalTrials.gov